U.S. pays $590 million to Moderna to speed up development of bird flu vaccine
The federal government is stepping up efforts to protect Americans from a growing threat: bird flu. With $590 million in new funding, Moderna will accelerate the development of a vaccine targeting pandemic influenza, including the unpredictable H5N1 virus. While bird flu has mostly impacted livestock, human cases are rising, with 67 confirmed infections. Outgoing HHS
Read & Share sourced from: MPR